Neurotrophins are a family of structurally related growth factors, including brain-derived neurotrophic factor (BDNF), that exert many of their effects on neurons through Trk receptor tyrosine kinases. Among these, BDNF and its receptor TrkB are the most widely and abundantly expressed in the brain. BDNF has been shown to regulate neuronal development and to modulate synaptic plasticity 1 . Obesity phenotypes have been observed in BDNF heterozygous mice and in mice in which the BDNF gene has been deleted in excitatory neurons in the brain 2-4 . These mutants also show hyperactivity, hyperleptinaemia, hyperinsulinaemia, hyperglycemia and increased linear growth 3,4 . Moreover, both central and peripheral administration of BDNF decrease food intake, increase energy expenditure and ameliorate hyperinsulinaemia and hyperglycemia in diabetic db/db mice 5-8 . However, the means by which BDNF alters energy balance and the relationship of TrkB signaling to the major pathways previously shown to be involved in the regulation of energy balance remain unknown.
Neurotrophins are a family of structurally related growth factors, including brain-derived neurotrophic factor (BDNF), that exert many of their effects on neurons through Trk receptor tyrosine kinases. Among these, BDNF and its receptor TrkB are the most widely and abundantly expressed in the brain. BDNF has been shown to regulate neuronal development and to modulate synaptic plasticity 1 . Obesity phenotypes have been observed in BDNF heterozygous mice and in mice in which the BDNF gene has been deleted in excitatory neurons in the brain [2] [3] [4] . These mutants also show hyperactivity, hyperleptinaemia, hyperinsulinaemia, hyperglycemia and increased linear growth 3, 4 . Moreover, both central and peripheral administration of BDNF decrease food intake, increase energy expenditure and ameliorate hyperinsulinaemia and hyperglycemia in diabetic db/db mice [5] [6] [7] [8] . However, the means by which BDNF alters energy balance and the relationship of TrkB signaling to the major pathways previously shown to be involved in the regulation of energy balance remain unknown.
The status of energy balance is communicated to the hypothalamus through neuronal and hormonal signals. Several hypothalamic nuclei are involved in the regulation of energy balance, including the ventromedial (VMH), paraventricular (PVN) and arcuate (ARC) hypothalamic nuclei and the lateral hypothalamic area (LH). Although the observation that bilateral VMH lesions produce hyperphagia and obesity has implicated this region in the regulation of energy balance [9] [10] [11] , the neural mechanisms through which the VMH functions to influence energy balance are not clear.
One of the major signals that serves as a monitor of energy balance is leptin, a polypeptide generated in adipocytes 12 . One of the main targets of leptin in the hypothalamus is the ARC, a region containing at least two distinct populations of neurons [13] [14] [15] . One population of neurons expresses two orexigenic polypeptides, neuropeptide Y (NPY) and agouti-related protein (AgRP), whereas the other expresses the anorexigenic polypeptides proopiomelanocortin (POMC) and cocaine-and amphetamine-regulated transcript (CART). Leptin suppresses food intake and increases energy expenditure at least partially by positively regulating the subset of neurons expressing POMC and CART and by negatively regulating the subset of those expressing NPY and AgRP. Other metabolic signals apart from leptin regulate the POMC-expressing neurons in the ARC; these include glucose, insulin, the gut peptide PYY and serotonin [16] [17] [18] [19] [20] . These melanocortin-expressing neurons thus seem to serve as one of the conduits for signals relevant to energy balance 21 .
Two melanocortin receptors, MC4R and melanocortin-3 receptor (MC3R), are expressed in the brain and play a critical role in the control of energy balance, especially the MC4R. In the agouti lethal yellow mutant (A y ), ectopic expression of the agouti protein (a homologue of AgRP) causes hyperphagia and obesity 22, 23 . The phenotype of the MC4R -/-null mutant is almost identical to that of the A y mutant, and consistent with this, the agouti protein has been shown to be an antagonist of MC4R, but not MC3R [24] [25] [26] . Hyperphagia resulting from abnormal feeding response to dietary fat probably contributes significantly to obesity in the MC4R -/-mice 27 .
Here we report that MC4R-and TrkB-mediated signaling are coupled in the regulation of energy balance. Our data show that signaling through the MC4R controls BDNF expression in the VMH, supporting a model in which BDNF functions as an important effector through which MC4R signaling regulates energy balance.
RESULTS

BDNF in the VMH is an anorexigenic factor
Expression of BDNF was examined in the hypothalamus by using a BDNF lacZ mouse strain in which the reporter gene for β-galactosidase, lacZ, is targeted to the BDNF locus 28 . BDNF is modestly expressed in some cells of the dorsomedial hypothalamus (DMH), but not in the ARC (Fig. 1a) . Only a small number of cells express BDNF in the LH. Consistent with in situ data 3 , BDNF is highly expressed in the VMH. Since bilateral VMH lesions produce hyperphagia and obesity [9] [10] [11] , this expression pattern suggests that BDNF in the VMH may suppress food intake and therefore may be regulated by feeding status. To test this, we examined BDNF expression in fooddeprived wild-type (WT) C57BL/6 mice with in situ hybridization. Food deprivation has been shown to increase expression of orexigenic neuropeptides while decreasing expression of anorexigenic neuropeptides 13, 15, 29 . Food deprivation specifically reduced the level of BDNF mRNA by 60% in the VMH (Fig. 1b-d) . In contrast, expression was not affected in the neocortex (Fig. 1d) .
Coexpression of TrkB and neuropeptides in the hypothalamus
BDNF might regulate energy balance through direct regulation of neuropeptides known to control energy balance. If so, the TrkB receptor should be coexpressed with these neuropeptides. We examined TrkB expression in the hypothalamus by using adult trkB lacZ /+ mice in which a tau-lacZ reporter gene is inserted into a trkB locus 30 , recapitulating the expression pattern of TrkB. Since the ARC and LH are two important brain regions in the control of feeding, we examined coexpression of TrkB and neuropeptides in these two nuclei. There was little coexpression of TrkB with melanin-concentrating hormone (MCH) or orexin in the LH and almost no expression of TrkB in neurons that express CART or NPY in the ARC (Fig. 2a-d) . Therefore, it is unlikely that BDNF directly modulates CART/POMC-and NPY/AgRP-expressing neurons in the ARC or MCH-and orexin-expressing neurons in the LH.
Reduction in TrkB expression leads to obesity
We previously described the generation-by insertion of a trkB cDNA into the first coding exon of the trkB locus-of a trkB hypomorph, fBZ/fBZ, that only expresses the full-length TrkB receptor tyrosine kinase at approximately a quarter of the normal amount in a normal pattern throughout the brain 30, 31 . The trkB hypomorph becomes severely obese (Fig. 3a) . The fBZ allele was backcrossed to the C57BL/6 genetic background for at least four generations before it was used to generate fBZ homozygous mice for characterization of the obesity syndrome. At 5 weeks of age, the trkB mutant started to show higher body weight compared to its wild-type littermate (Fig. 3c,d ). By 12 weeks, both female and male trkB mutants were markedly heavier than their wild-type littermates. The body weight of fBZ heterozygous mice was similar to that of the wild-type littermates, indicating that fBZ is a recessive mutation. To determine whether weight gain in the trkB mutant is due to increased adiposity, we dissected and weighed four different fat pads from three female fBZ/fBZ mice and three female wild-type littermates at 12 weeks of age. The mass of each was greatly increased in the trkB hypomorph (brown fat, 0.92 ± 0.10 g in the mutant vs. 0.12 ± 0.06 g in the WT control, P < 0.01; subcutaneous fat, 5.08 ± 1.43 g vs. 0.52 ± 0.16 g, P < 0.01; uterine fat, 5.38 ± 2.63 g vs. 0.31 ± 0.12 g, P < 0.05; perirenal fat, 1.14 ± 0.11 g vs. 0.17 ± 0.02 g, P < 0.01).
The trkB mutant showed altered linear growth when body length (naso-anal) was measured at approximately 3 months of age. The mean lengths of male and female fBZ/fBZ mice were increased approximately 8% and 13%, respectively, compared to controls (Fig. 3b) . Feeding behavior of the trkB hypomorph The development of obesity in the trkB mutants indicates that these animals have elevated energy intake relative to energy expenditure. Phenotypic effects on energy consumption were first examined by determining the daily food intake of the trkB mutants at 5 and 9 weeks of age. The mutants showed a marked hyperphagia at both ages, consuming 75% more food than controls (Fig. 4a) . This likely contributes substantially to their development of obesity. To determine the impact of the trkB mutation on patterns of ingestive behavior, mice were habituated to single housing for 6 d in cages equipped to continuously monitor feeding and drinking activity. Mice were then monitored for an additional 8 d, and data from these days were averaged for examination of intake patterns. The intake patterns are shown for a mutant and wildtype littermate pair (Fig. 4b,c) . Similar to the patterns observed for this pair, mutants frequently engaged in prolonged periods of feeding and drinking in comparison to wild-type controls. These episodes were most frequent during the dark cycle but also occurred during the light cycle. In addition, prolonged periods of quiescence were commonly observed during the light cycle. Accompanying alterations in the circadian distributions of feeding and drinking were also seen, such that the percentages of total food and water intake during the dark cycle were decreased in the mutant mice (chow: WT 78 ± 2%, fBZ/fBZ 64 ± 3%, P = 0.001;
water: WT 84 ± 2%, fBZ/fBZ 66 ± 3%, P < 0.001). Overall, the trkB mutants were found to be significantly hyperphagic and hyperdipsic during both the light and dark cycles ( Fig. 4d ,e).
MC4R regulates BDNF expression in the VMH
These phenotypic analyses indicate that the trkB hypomorph is remarkably similar to the MC4R -/-null mutant in development of obesity. The trkB hypomorph and MC4R -/-mutant show maturity-onset obesity and increased linear growth. In addition, they have similar sex differences in the obesity syndrome. For example, female and male fBZ/fBZ mice, on average, are 107% and 50% heavier than their sex-matched wild-type littermates at 12 weeks of age ( Fig. 3c,d ). Similarly, female and male MC4R -/-null mice, on average, are 100% and 50% heavier than their sex-matched wild-type littermates at 15 weeks of age 24 . Moreover, linear growth in these two mutants is increased over wild-type mice to a similar extent (13% in fBZ/fBZ vs. 11% in MC4R -/-in females; 8% in fBZ/fBZ vs. 7% in MC4R -/-in males). (c) Weight gain of female homozygous fBZ/fBZ mutant mice (n = 7), heterozygous fBZ/+ mice (n = 7) and wild-type (+/+) controls (n = 5). When the female mutant mice were 5 weeks or older, their body weights were significantly higher than those of their female +/+ or fBZ/+ littermates (P < 0.05 by two-tailed Student's t-test). (d) Weight gain of male homozygous fBZ/fBZ mutant mice (n = 6), heterozygous fBZ/+ mice (n = 4) and wild-type (+/+) controls (n = 5). When the male mutant mice were 7 weeks or older, their body weights were significantly higher than those of their male +/+ or fBZ/+ littermates (P < 0.05 by two-tailed Student's t-test). To examine whether MC4R signaling regulates BDNF expression in the VMH, we first determined whether POMC-or AgRP-expressing neurons project to the VMH in mice. We used antibodies to gammamelanocyte-stimulating hormone (γMSH), a POMC-derived peptide, to reveal POMC fibers ( Supplementary Fig. 1 online) . Consistent with what has been reported in rats 32 , the number of POMC-immunoreactive fibers in the VMH is fewer than the number in the DMH, but is comparable to the number observed in the LH. As the POMC fibers in the VMH contain boutons, these fibers must innervate VMH neurons. Similarly, VMH neurons also receive innervation from AgRP-immunoreactive fibers ( Supplementary Fig. 1 online) . In addition, there are substantial numbers of POMC and AgRP fibers surrounding the VMH, which may innervate dendrites extending from neurons within the VMH.
Next we quantified expression of BDNF by using in situ hybridization in the A y mutant in which ectopically expressed agouti blocks the function of the MC4R 22, 23, 26 . Compared to sex-matched wild-type littermates, BDNF expression in the VMH was reduced by 30-40% in the A y mutant (Fig. 5a) . The data suggest that reduction in MC4R signaling results in downregulation of BDNF expression in the VMH. We also used in situ hybridization to quantify BDNF expression in the VMH of MC4R -/-mice, demonstrating that it is also significantly reduced in the VMH (Fig. 5b) . To determine whether MC4R signaling acutely regulates the level of BDNF mRNA in the VMH, we used wild-type mice to examine the possibility that administration of a melanocortin receptor agonist reverses the inhibitory effect of food deprivation on BDNF expression in the VMH. Similar to the results shown in Fig. 1 , 47 h of fasting resulted in an approximately 65% reduction in the level of BDNF mRNA in the VMH that was not prevented by intracerebroventricular injection of artificial cerebrospinal fluid (ACSF; Fig. 5c ). Compared to ACSF administration alone, however, administration of an MC4R agonist, MTII, significantly increased (by ∼70%) the level of BDNF mRNA in the VMH of food-deprived mice within 3 h of treatment (Fig. 5c) . Although the level of BDNF mRNA in the VMH of MTII-treated fooddeprived mice was still significantly lower than that in the VMH of vehicle-treated fed mice, these results indicate that the melanocortin pathway is at least partially responsible for downregulation of VMH BDNF during food deprivation.
MC4R regulates BDNF expression in selective VMH neurons
Neurons in hypothalamic nuclei are extremely heterogeneous. To determine whether ectopic expression of agouti reduces expression of BDNF in all BDNF-expressing VMH neurons or selectively abolishes BDNF expression in only some, we crossed the BDNF lacZ /+ mouse to the A y mutant and used β-galactosidase as a marker to examine the effect of agouti on expression of BDNF. Compared with BDNF lacZ /+ mice, fewer neurons expressed BDNF in the VMH of A y /a;BDNF lacZ /+ mice ( Fig. 6a-d) . Furthermore, it appeared that the number of neurons expressing BDNF in the caudal part of the VMH was more severely reduced in A y mice (Supplementary Fig. 2 online) . The effect of agouti on BDNF expression seems specific to the VMH. BDNF expression in the A y mutant remains normal in the DMH, LH (Fig. 6a,b) , PVN Figure 5 Melanocortins regulate the levels of BDNF mRNAs in the VMH. (a) Expression of BDNF in the VMH is significantly reduced in the A y mutant. Expression levels of BDNF in the VMH were determined with in situ hybridization on C57BL/6J-A y /a mice and C57BL/6J wild-type littermates at 7-9 weeks of age. In the first experiment, we used four male wild-type mice (25.9 ± 1.7 g) and three male A y /a mice (28.5 ± 1.3 g). In experiment 2, we used two males and one female for each genotype. (b) Deficiency in MC4R signaling reduces expression of BDNF in the VMH. Expression levels of BDNF in the VMH were determined with in situ hybridization on male MC4R -/-null mutants (n = 6) and C57BL/6J wild-type mice (n = 6) at 10 weeks of age. (c) Intracerebroventricular injection of MTII increased the levels of BDNF mRNAs in the VMH of food-deprived mice. ACSF (n = 5) or MTII (n = 4) was injected into the third ventricle of food-deprived female C57BL/6J wild-type mice at 10 weeks of age. As a control, ACSF was also injected into the third ventricle of normally fed female C57BL/6J mice (n = 5). The levels of BDNF in the VMH were determined with in situ hybridization on cryostat brain sections as described in Methods. Two-tailed Student's t-test, *P < 0.05, **P < 0.01. (Fig. 6e,f) , hippocampus and cerebral cortex (data not shown). Reduction in the number of BDNF-expressing neurons in the VMH is unlikely to be due to cell death because cresyl violet staining shows a normal VMH in the A y /a;BDNF lacZ /+ mutant (data not shown).
To further confirm that melanocortins acutely regulate BDNF expression in the VMH, we injected MTII into the dorsal third ventricle of A y /a;BDNF lacZ /+ mice. MTII injection increased the number of intensely stained neurons in the area of the VMH where expression of BDNF is reduced in the A y mice (Fig. 6h,i) . Compared to saline-injected brains, the number of neurons expressing β-galactosidase was increased by 39% in the caudal VMH of MTII-treated brains (P = 0.017) (Fig. 6g) . Thus, results indicate that an MC4R agonist acutely increases expression of BDNF in a set of VMH neurons, even in the presence of the MC4R antagonist agouti. This is consistent with the previous observation that MTII injection significantly inhibits food intake in A y mice 33 .
TrkB regulates feeding response to dietary fat
On the basis of these findings, we reasoned that BDNF may be a downstream component in the MC4R-mediated control of energy balance. MC4R is required for the feeding response to dietary fat 27 . Transition from a low-fat diet (Purina diet 5001, 12.8% fat calories) to a moderatefat diet (Purina diet 5015, 25.1% fat calories) leads to a dramatic increase in energy intake and rate of weight gain in the MC4R -/-mice, but does not increase the rate of weight gain in wild-type mice. In contrast, leptin-deficient ob/ob mice are similarly hyperphagic on both the lowfat and moderate-fat diets and do not exhibit an increase in the rate of weight gain on the moderate-fat diet 27 . To examine whether mice with deficient BDNF-mediated signaling exhibit an abnormal response to the moderate-fat diet similar to that of MC4R -/-mice, the weight and food intake of the animals were monitored for 3 d on the low-fat diet and then for 7 d on the moderate-fat diet, followed by another 4 d on the low-fat diet. Female fBZ/fBZ mice gained weight to a similar extent as control mice (WT or fBZ/+ mice) on the low-fat diet, but gained weight at a markedly increased rate on the moderate-fat diet (Fig. 7a) . Male fBZ/fBZ mice showed a similar abnormal response in weight gain to the diet transition (data not shown).
The weight gain in the fBZ/fBZ mice was associated with a sharp increase in energy intake on the moderate-fat diet (Fig. 7b) . The trkB mutant mice and their littermate controls consumed a similar amount of the low-fat diet ( Fig. 7c; 4.9 ± 0.2 g for controls vs. 5.4 ± 0.4 g for fBZ/fBZ, P = 0.307). Transition from the low-fat to the moderate-fat diet led control mice to significantly reduce food intake (4.9 ± 0.2 g on the low-fat diet vs. 3.9 ± 0.2 g on the moderate-fat diet, P = 0.003), thereby maintaining a similar energy intake level (Fig. 7b,c) . In contrast, the fBZ/fBZ mice greatly increased food intake after the diet was switched (Fig. 7b) . On average, the fBZ/fBZ mice ingested 71% more calories on the moderate-fat than on the low-fat diet (Fig. 7c) . These results indicate that activation of the TrkB receptor is required for the normal feeding response to elevated dietary fat.
We then determined whether BDNF is downstream of MC4R by attempting to suppress with infusion of BDNF into the brain hyperphagia and the increased rate of weight gain observed in A y mice on the moderate-fat diet. For two weeks, PBS or BDNF (50 ng/h) were infused into the lateral ventricles of female A y and WT C57BL/6 littermates using osmotic pumps. Transition from the low-fat to the moderate-fat diet led to an increase in energy intake in the PBS-treated A y mice ( Fig. 7d; 11.2 ± 0.4 kcal on the low-fat diet vs. 14.0 ± 0.5 kcal on the moderate-fat diet, P < 0.001). BDNF infusion significantly suppressed hyperphagia in the A y mice on the moderate-fat diet without altering energy intake on the low-fat diet (Fig. 7d) . Transition from the low-fat to the moderate-fat diet led to a faster weight gain in the PBStreated A y mice than in the PBS-treated, wild-type mice. BDNF infusion reduced the rate of weight gain in these A y mice on the moderate-fat diet to a level similar that observed in wild-type mice (Fig. 7e) . Over the 9-d period on the moderate-fat diet, BDNF infusion did not significantly reduce weight gain in wild-type mice (P = 0.244), but greatly reduced it in the A y mice from 15.3% to 7.6% (P = 0.0027) (Fig. 7f) . The data support a model in which BDNF at least partially mediates the effect of MC4R on the feeding response to dietary fat.
DISCUSSION
Although bilateral lesions in the VMH produce hyperphagia and obesity, the mechanism through which VMH neurons control energy balance is not known. Our results show that BDNF is highly expressed in Figure 7 TrkB acts downstream of MC4R to regulate feeding response to dietary fat. (a,b) Body weight and energy intake of female fBZ/fBZ (n = 4) and control littermates (+/+ or fBZ/+, n = 4). The average weights of the fBZ/fBZ and control mice at the start of the experiment were 21.7 ± 1.1 and 19.0 ± 0.6 g, respectively. (c) Average daily energy intake of fBZ/fBZ (n = 8) and control littermates (n = 9) on the low-fat and moderate-fat diets. The daily energy intake on two diets is an average from 7 d on the low-fat diet and 7 d on the moderate-fat diet, respectively. (d) BDNF infusion did not affect energy intake of the A y mice on the low-fat diet, but did suppress their energy intake on the moderate-fat diet. The daily energy intake on the low-fat diet and moderate-fat diet is an average from the first 3 d and the last 8 d of the study, respectively. the VMH where its expression is regulated by nutritional state. We are not aware of another molecule in the VMH that is regulated by food deprivation. Furthermore, our results show that MC4R-mediated signaling stimulates expression of BDNF in the VMH and that infusion of BDNF into the brain rescues the abnormal feeding response of A y mice to dietary fat. These results suggest that BDNF is one of the molecules that mediate the function of the VMH in the control of energy balance. As BDNF is a key regulator of neuronal development, neurodevelopmental anomalies may contribute to the obesity phenotype in BDNF and trkB mutant mice. Substantial evidence indicates, however, that the defect of energy homeostasis in these mutants does reflect an adult function of BDNF. First, infusion into the adult brain of BDNF, but not NGF or NT-3, reverses hyperphagia and obesity of BDNF +/-mice 3 . Second, deletion of the BDNF gene in the brain, using a cre transgene under the control of the Ca 2+ /calmodulindependent kinase II (CaMKII) promoter leads to obesity 4 . Most developmental processes have been completed before this promoter is first activated during the third week of postnatal development. Third, administration of BDNF increases energy expenditure in db/db mice 6 . Fourth, food deprivation specifically reduces the level of BDNF mRNA in the VMH (Figs. 1 and 5) . Finally, MC4R signaling regulates BDNF expression in the VMH (Figs. 5 and 6) . Therefore, the obesity phenotypes observed in BDNF and trkB mutants cannot completely result from developmental anomalies.
There are several possible mechanisms through which MC4R signaling could influence BDNF expression in the VMH. One possibility is direct signaling through MC4R-expressing neurons within the VMH. MC4R is expressed within the VMH and the VMH receives innervations from arcuate POMC-or AgRP-expressing neurons 32, 34 . The level of POMC innervation within the VMH is low, but is comparable to that in the LH (Supplementary Fig. 1 online) . In addition, there are a substantial number of POMC and AgRP fibers surrounding the VMH. These fibers may innervate the dendrites extending from neurons within the VMH 35 , thereby regulating BDNF expression within the VMH. Finally, it is also possible that regulation involves one or more additional neurons that may reside outside of the VMH and whose projections control BDNF expression within the VMH.
Food deprivation for 2 d results in a ∼2/3 reduction in the levels of BDNF mRNAs in the VMH, which is substantially but incompletely reversed by administration of an MC4R agonist. Among potential reasons for the incompleteness of reversal are suboptimal activation of MC4R receptors due to poor penetration or rapid turnover of MTII, assay of BDNF mRNA before elevated synthesis has established a new equilibrium level, and possible involvement of additional signaling pathways whose activities are regulated by feeding status, but do not involve the MC4R.
Where are the TrkB-expressing neurons through which BDNF regulates feeding behavior and energy balance? Targeted deletion of a floxed BDNF allele with a CaMKII-driven cre results in obesity 4 , suggesting that the BDNF-expressing neurons in the VMH are probably a population of excitatory neurons that express endogenous CaMKII. BDNF is anterogradely transported to postsynaptic neurons in an activitydependent manner 36 , so the TrkB-expressing neurons could be located in any of the brain regions that receive projections from the VMH. Neurons in the VMH project to many targets within and outside the hypothalamus, including the DMH, anterior hypothalamus, bed nuclei of the stria terminalis, amygdalar nuclei, nucleus of the solitary tract and periaqueductal gray [37] [38] [39] . Some of these targets such as the DMH, nucleus of the solitary tract and periaqueductal gray have been implicated in the regulation of energy intake [40] [41] [42] . To identify the cells through which TrkB regulates feeding behavior will require extensive analyses using region-specific and cell type-specific elimination and overexpression of the TrkB receptor.
It has been shown that BDNF is required for gustatory development 43, 44 and that TrkB is expressed in the olfactory bulb 45 . Since the moderate-fat diet is more palatable, these observations raise the possibility that developmental defects and/or malfunction of the gustatory or olfactory system may affect feeding behavior of the trkB mutant on the moderate-fat diet. A defect in the gustatory or olfactory system most likely results in loss of the ability to distinguish the low-fat diet and moderate-fat diet in the trkB mutant. If so, a gustatory or olfactory defect may reduce ingestion of the moderate-fat diet. Therefore, a defect in the gustatory or olfactory system is unlikely to significantly contribute to hyperphagia on higher fat diets in the trkB mutant.
In conclusion, our results indicate that BDNF-to-TrkB signaling is an important downstream target of MC4R-mediated signaling that participates in the regulation of energy balance and feeding behavior. The obesity phenotypes observed in animals with compromised MC4R and TrkB signaling thus seem to be caused by deficits in different steps of a common or overlapping signaling pathway. In the future, it will be important to identify the neurons and cellular mechanisms that control each step of this pathway.
METHODS
Mouse strains. Mice were maintained on a normal 12 h/12 h light/dark cycle with regular mouse chow and water ad libitum. A y mice and wild-type littermates were purchased from the Jackson Laboratories. Generation of fBZ/+, trkB lacZ /+ and BDNF LacZ /+ mice were as described previously 28, 30, 31 . The MC4R -/-null mice were offspring from crosses between MC4R -/-mice that had been backcrossed to C57BL/6J for five generations. The control C57BL/6J wild-type mice were purchased from Jackson Laboratories. Animal procedures were approved by the University of California San Francisco Committee on Animal Research.
Feeding behavior. Mice were individually housed for at least 3 d before measurement. Over 5 d, regular mouse chow was weighed and provided to 5-or 9-week old mice ad libitum with measurement at noon each day and careful monitoring for spillage. Each group consisted of three females and two males. The 5-week control group contained one fBZ heterozygous and four wild-type mice, whereas the 9-week control group consisted of three fBZ heterozygous and two wild-type mice.
Low-fat Purina diet 5001 (23.0% protein, 4.5% fat, 5.3% crude fiber, 49% carbohydrate, total digestible nutrient 76%, 3.04 kcal/g metabolizable energy) and moderate-fat Purina diet 5015 (17.0% protein, 11.0% fat, 3.0% crude fiber, 53.5% carbohydrate, total digestible nutrient 88%, 3.73 kcal/g metabolizable energy) were used to monitor the feeding response of mice to dietary fat. Mice were isolated and fed with Purina diet 5001 one week before any measurement of food intake and body weight. Histology. X-gal staining and immunohistochemistry were performed as described previously 31 . Anti-β-galactosidase (1:4,000) was from Cappel Research Reagents. Anti-γ-MSH and anti-AgRP were provided by S. Watson (University of Michigan, Ann Arbor, Michigan) and G. Barsh (Stanford University, Stanford, California), respectively.
For in situ hybridization, mice were anesthetized and fixed with sequential transcardial perfusion of PBS and 4% paraformaldehyde. The brains were dissected, immersed in 30% sucrose, and then frozen. Alternatively, mice were killed by neck dislocation and the brains were dissected and frozen immediately. BDNF in situ hybridization was performed on cryostat coronal sections at 30 µm using 35 S-labeled antisense RNA probes complementary to the coding region of the mouse BDNF cDNA. After hybridization and washes, sec-tions were exposed on Beta-Max Hyperfilm (Amersham). Images from two sections that covered the caudal VMH and were separated by 150 µm in each mouse were scanned at 1,200 d.p.i. and the optical density of in situ signals was determined using NIH Image.
MTII injection.
Ten-week-old female wild-type C57BL/6J mice were fooddeprived for 44 h and anesthetized with avertin. The dorsal third ventricle (2 mm caudal from bregma, 2.5 mm deep) was injected with 4 nmol MTII (Bachem) or artificial cerebrospinal fluid (ACSF) in a volume of 3 µl with a Hamilton syringe over a 20-s period. ACSF was also injected into a group of normally fed mice. The needle stayed in the brain for another 15 s before it was removed. Three hours later, mice were killed by cervical dislocation, and their brains were immediately dissected out and frozen.
To determine the effect of MTII injection on expression of BDNF in A y mice, 3 nmol of MTII or saline was intracerebroventricularly injected into A y /a; BDNFlacZ/+ mice. Six hours later, the brains were fixed and processed for anti-β-galactosidase immunohistochemistry. The VMH of each brain at approximately bregma -1.8 mm was photographed, and β-galactosidase-expressing neurons were counted (by an experimenter blind to treatment group).
BDNF infusion. Female A y mice and wild-type littermates were isolated and fed with Purina diet 5001 one week before pump implantation. Alzet osmotic pumps (model 1002, 0.25 µl/h for 14 d) were filled with PBS or human recombinant BDNF (Amgen) in PBS at a concentration of 200 ng/µl. The dosage of BDNF was chosen according to a previous study 3 . Pumps were then attached to an Alzet brain infusion kit and the entire apparatus was primed overnight in sterile saline at 37 °C. The tip of an infusion catheter was positioned in the lateral ventricle (0.5 mm caudal and 1 mm lateral from bregma, 2.5 mm deep) of mice anesthetized with avertin and secured with Loctisite gel. Starting a day after surgery, body weight and food intake were measured daily. Upon completion of the 2-week study, the position of the cannula tip and the volume of remaining solution in the pump were determined. Animals were excluded from analysis if they died (n = 1), appeared sick (n = 1) or had misplaced or malfunctioning pumps (n = 2).
